Ozempic’s maker is in trouble. Tablets may be the answer
Just a few years ago, Novo Nordisk was the darling of the healthcare industry.
Now it is teetering.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.theage.com.au — the content belongs to The Age - Home.